Otte, Maximillian, Dauben, Hans Peter, Ahn, Jeonghoon et al. (5 more authors) (2024) Value based healthcare and Health Technology Assessment for emerging market countries:joint efforts to overcome barriers. Expert Review of Pharmacoeconomics & Outcomes Research. pp. 1061-1066. ISSN: 1744-8379
Abstract
Introduction This paper summarizes the results from a forum of healthcare experts, academia representatives, and public agency officials from emerging and established market countries on Value-Based Healthcare (VBHC) and Health Technology Assessment (HTA). Presentations from experts provided insights into current developments and challenges, followed by interactive roundtable discussions. Emerging markets have unique healthcare systems, patient populations, resource constraints and needs. Areas covered Each roundtable explored specific topics including the role of HTA and Real-world evidence (RWE) in healthcare decision-making, challenges in biosimilar value assessment and incorporating non-price criteria reflecting context-related specifications of emerging markets such as the multifaceted nature of value in healthcare decision-making, emphasizing stakeholder perspectives and system complexities. Expert opinion RWE emerged as important in understanding biosimilar value recognition and decision-making processes, with insights into its applications and challenges. Recommendations were provided for utilizing Multi-Criteria Decision Analysis (MCDA) in pharmaceutical procurement, particularly for off-patent medicines, underscoring the importance of comprehensive evaluation frameworks and adherence to value-based principles. Overall findings suggest avenues for collaboration between industry, academia, and public agencies to address implementation barriers and promote equitable, efficient, and high-quality healthcare systems in emerging markets through public–private partnerships, joint capacity building and training initiatives, and knowledge transfers.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2024 The Author(s). |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) |
Date Deposited: | 01 Oct 2025 09:50 |
Last Modified: | 01 Oct 2025 09:50 |
Published Version: | https://doi.org/10.1080/14737167.2024.2398482 |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1080/14737167.2024.2398482 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:232429 |
Download
Description: Value based healthcare and Health Technology Assessment for emerging market countries joint efforts to overcome barriers
Licence: CC-BY-NC-ND 2.5